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60 The Journal of Thoracic and Cardiobjective: Atrial fibrillation is one of the most common complications in patients
ndergoing coronary artery bypass grafting. The goal of this study was to investigate
he impact of high thoracic epidural anesthesia on reduction of perioperative
rrhythmia in patients undergoing off-pump coronary artery bypass grafting.
ethods: We prospectively randomized 132 patients undergoing elective off-pump
oronary bypass grafting using either general anesthesia (GA) (n 66) or combined
eneral and high thoracic epidural anesthesia (GATEA) (n  66). Incidence of
erioperative arrhythmias such as atrial fibrillation, serum epinephrine levels, heart
ate variability, and hemodynamic parameters were compared between groups.
esults: The incidence of perioperative dysarrhythmias was significantly lower
P .01) in the GATEA group (3%) than in the GA group (23.7%). Intraoperative
inus bradycardia occurred in 91% of the patients in the GATEA group versus
.3% in the GA group. After induction of anesthesia, the mean systolic arterial
ressure decreased significantly from 128  5 to 92  4 mm Hg and the heart rate
rom 74  9 to 52  8 beats · min1 in the GATEA group, whereas in the GA
roup no significant hemodynamic changes were observed (P  .001). Serum
pinephrine levels were significantly lower in the GATEA group (69  11 to
5  7 ng/dL) than in the GA group (72  9 to 70  9 ng/dL).
onclusions: In our study cohort, high thoracic epidural anesthesia in combination
ith general anesthesia reduced significantly the incidence of perioperative arrhyth-
ias such as atrial fibrillation. Furthermore, we observed a significant reduction of
pinephrine serum levels in this patient group. The results of this study support a
ombination of general anesthesia with thoracic epidural anesthesia as a multidis-
iplinary approach, which may lead to a better patient outcome, improvement of
arly analgesia, and reduction of perioperative complications in off-pump coronary
rtery bypass procedures. The potential risks of thoracic epidural anesthesia during
ff-pump coronary artery bypass procedures should not be underestimated.
erioperative arrhythmias such as atrial fibrillation (AF) are the most common
complications in patients undergoing off-pump coronary bypass grafting
(OPCAB), with a reported prevalence of 5% to 29%.1-5 The etiology of A
s not widely known and has been related to many risk factors.6-8 Activation of th
utonomic nervous system seems to enhance or trigger the initiation and perpetu-
tion of AF.9 Recent studies have also reported that prophylactic administratio
-blocker therapy may reduce the incidence of postoperative AF and reduce the
ength of hospital stay after cardiac surgery.10,11
General anesthesia (GA) is the most commonly used anesthetic technique and isonsidered the “gold standard” for coronary artery bypass grafting (CABG) per-
vascular Surgery ● August 2007
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A
CDormed either on pump or off pump.12 Within the past few
ears, however, high thoracic epidural anesthesia (TEA) as
n adjunct to GA has become more prevalent and has been
hown to be potentially beneficial in patients with coronary
rtery disease.13 Potential advantages of TEA include th-
acic sympathicolysis with subsequent improvement of cor-
nary perfusion, decreased heart rate, the latter being par-
icularly important in OPCAB, decreased endogenous stress
esponse, and a reduced risk for preoperative myocardial
schemia. Furthermore, improved postoperative pulmonary
nd gastrointestinal function with concomitant decreases in
orbidity and mortality has been reported.12 Additionally,
ostoperative pain management is facilitated by continuous
pidural application of analgesics. Such effective pain man-
gement improves postoperative mobilization and recov-
ry.12 The risks associated with TEA are infections 
ematoma formation with subsequent adverse neurologic
equelae.13 The aim of the present trial was to verify
rospective randomized design whether the use of TEA
eads to a reduction of perioperative arrhythmias in patients
ndergoing OPCAB.
aterials and Methods
fter approval by the institutional ethics board and with written
nformed consent, a total of 132 patients with symptomatic coro-
ary artery disease were prospective enrolled in this study. All
atients underwent elective OPCAB surgery and were randomized
o receive either GA or combined GATEA. Patients with a
istory of atrial arrhythmias, those undergoing emergency opera-
ions, and patients requiring intraoperative inotropic support were
xcluded from this study. The incidence of perioperative arrhyth-
ias such as AF, serum epinephrine levels, heart rate variability,
nd hemodynamic parameters were compared between the two
roups. The hypothesis of the study was to determine whether the
mpact of the TEA in reduction of perioperative dysarrhythmias
ould be demonstrated in patients undergoing OPCAB.
urgical Technique
he chest was opened either by complete sternotomy for double or
riple CABG or by partial lower ministernotomy for single CABG.
small pediatric thorax retractor (Aeskulap, Tüttlingen, Germany) was
sed for exposition and harvesting of the left internal thoracic
rtery. Intravenous heparin was given in a standard dose of 150
U/kg after thoracic artery dissection. A 75% reversal of heparin
Abbreviations and Acronyms
AF  atrial fibrillation
CABG  coronary artery bypass grafting
ECG  electrocardiogram
GA  general anesthesia
OPCAB off-pump coronary artery bypass grafting
TEA  high thoracic epidural anesthesiaas performed with intravenous protamine at thorax closure. The a
The Journal of Thoracica
ctivated coagulation time was measured to ensure appropriate
eparin effect and reversal. An activated clotting time around 250
econds during the operation was attained. After creating a peri-
ardial cradle, the surgeon exposed the target vessels and used
ctopus 4 (Medtronic Inc, Minneapolis, Minn) for stabilization of
he target vessels. Anastomoses were performed in standard beat-
ng heart bypass technique using proximal control of the target
oronary artery with a vessel loop and a blower mister to clear the
nastomotic site.
A and TEA
ntiplatelet therapy was stopped 5 days before the operation in all
ases. In the TEA group, a multiport epidural catheter (Perifix Soft
05; B. Braun Melsungen AG, Melsungen, Germany) was inserted
t the T1/2 or T2/3 intercostal space on the day before the oper-
tion. On the day of the operation, all patients were premedicated
ith oral midazolam, 7.5 mg.
On arrival of the patient in the preoperative holding area,
ntravenous access and direct blood pressure monitoring by cath-
terization of the radial artery were established regardless of the
nesthetic technique used. In patients receiving TEA, a continuous
pidural infusion with ropivacaine 0.16% and sufentanil 1 g · mL1 at
n hourly rate of 2 to 5 mL was started after a bolus dose of 6 mL
o provide intraoperative analgesia.
After induction of general anesthesia, a central venous line was
nserted and correct placement confirmed by intra-atrial electro-
ardiographic (ECG) lead (Alphacard; B.Braun AG, Melsungen,
ermany). Additional monitoring consisted of continuous auto-
ated ST-segment analysis at J  60 ms for leads I, II, and V5
Hellige Marquette Solar 8000 Patient Monitor; Marquette Medi-
al Systems, Milwaukee, Wis). An ST-segment alteration of 1 mm
r more (0.1 mV) persisting more than 60 seconds was considered
significant alteration from baseline. Oxygenation and ventilation
ere continuously monitored by pulse oximetry and capnography.
ody temperature was maintained in all patients with a warming
lanket (Bair Hugger model 505; Augustine Medical, Inc, Eden
rairie, Minn) and continuously monitored with a rectal tempera-
ure probe.
Anesthesia was induced with propofol (1.5 mg · kg1) and
emifentanil (1 g · kg1) administered over 120 seconds. After
oss of eyelash reflex, 0.1 mg · kg1 of cisatracurium was admin-
stered to facilitate tracheal intubation. Anesthesia was maintained
ith continuous infusion of propofol (50-100 g · kg1 · min1)
nd remifentanil (0.1-0.3 g · kg1 · min1). Positive-pressure
entilation with oxygen 50% in air was used. Tidal volume (8-10
L · kg1) and respiratory rate (10-12 min1) were adjusted
ccording to the end-tidal pressure of carbon dioxide to achieve nor-
al ventilation (end-tidal pressure of carbon dioxide 35-40 mm Hg).
atients undergoing GA without TEA received intravenous met-
mizole (Novalgin; Aventis Pharma, Bad Soden, Germany), a
eripheral analgesic derived from pyrazolone acid, 15 mg · kg1,
efore skin incision. Intravenous piritramide, a -receptor agonist
ith a potency of 0.7 compared with morphine, 0.1 mg · kg1, was
dministered after completion of coronary anastomosis and re-
eated during wound closure. The thoracic epidural catheter was
sed for not only intraoperative but also postoperative pain man-
gement for 3 days. Depending on pain perception, patients re-
and Cardiovascular Surgery ● Volume 134, Number 2 461
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4
A
CDeived additional analgesics and sedative hypnotic agents, as rou-
inely used in our department.
Monitoring included arterial and central venous blood pressure
easurement, ECG (leads II, aVF, and V5), pulse oximetry, and
nd-tidal carbon dioxide (Hellige Marquette Solar 8000 Patient
onitor, Marquette Medical Systems, Milwaukee, WI). Any
ewly developed sustained episode of cardiac arrhythmia was
etected and printed with a continuous monitoring ECG system
Hellige Marquette Solar 8000 Patient Monitor; Marquette Medi-
al Systems, Milwaukee, Wis) with automatic arrhythmia analysis
or 48 hours. Thereafter, twice daily 12-lead ECGs were per-
ormed until hospital discharge and in each case with clinical
ymptoms caused by rhythm disturbance. In the case of docu-
ented arrhythmia, continuous ECG monitoring was restarted. AF
as defined an episode of atrial fibrillation or flutter lasting for
ore than 30 seconds.
tatistical Analysis
ata were compiled and analyzed with Microsoft Excel (Red-
ond, Wash) and StatView (SAS Institute, Inc, Cary, NC). The
aseline characteristics and hospital outcomes for both groups
ere compared by 2 contingency or the Fisher exact test 
ategorical data and the Mann–Whitney U test for continuous
ariables. Results are reported as the mean standard deviation in
ext and tables.
esults
here were no significant differences in preoperative clini-
al characteristics including gender, sinus rhythm, left ven-
ricular ejection fraction, preoperative antiarrhythmic med-
cation, and cardiovascular risk factors between the two
roups (Table 1).
Table 2 demonstrates operative data, incidence of 
hythmias, and the time of onset of perioperative AF. There
ABLE 1. Patient characteristics
GA GATEA P value
66 66
ge (y) 64 9 66 8 NS
ale 58 54 NS
enal insufficiency 32 25 NS
eripheral arterial disease 21 18 NS
erebrovascular disease 14 17 NS
uroSCORE 6.2 4 5.4  6 NS
inus rhythm 66 66 NS
reoperative -blocker 32 35 NS
VEF
55% 46 48 NS
35%-55% 20 18 NS
revious MI 37 36 NS
eft main disease 34 33 NS
A, General anesthesia; TEA, high thoracic epidural anesthesia; NS, not
ignificant; LVEF, left ventricular ejection fraction; MI, myocardial
nfarction.as no significant difference between the operation time, a
62 The Journal of Thoracic and Cardiovascular Surgery ● Augulood loss, ventilation time, and numbers of distal anasto-
oses. No relevant TEA-related complications such as
uncture site infection, epidural hematoma, nerve injury,
eurologic deficits, accidental dura puncture, or lower-limb
otor block were observed. However, women, especially,
ere more prone to nausea and vomiting in the GATEA
roup. There was no in-hospital mortality in either group.
he incidence of perioperative AF was significantly lower
P  .01) in the GATEA group (3%) than in the GA
roup (23.7%). Time of onset of AF did not differ between
he two groups. Patients with AF lasting more than 10
inutes or those requiring medical attention because of
emodynamic instability were treated with -blockers
metoprolol 100 mg/d), amiodarone (5 mg/kg over 60 min-
tes followed by infusion of 1200 mg/d), or digitoxin and
lectrical cardioversion (in case of hemodynamic instability
r failure of pharmacologic treatment). Anticoagulation
ith heparin was started routinely. Intraoperative sinus bra-
ycardia occurred in 91% of the patients in the GATEA
roup versus 5.3% in the GA group. After induction of
nesthesia, the mean systolic arterial pressure decreased
ignificantly from 128  5 to 92  4 mm Hg and heart rate
rom 74  9 to 52  8 beats · min1 in the GATEA
roup, whereas in the GA group no significant hemody-
amic changes were observed (Figure 1; P  .001). We
bserved one case of ventricular fibrillation in each group.
Serum epinephrine levels were significantly lower in
roup GATEA (69  11 to 35  7 ng · dL1) than in in
roup GA (72  9 to 70 9 ng · dL1; P  .001) (Figure 2)
The incidence of nonsustained ventricular extrasystole
as significantly lower (P  .01) in the GATEA group.
here was no case of myocardial infraction in either group.
ength of hospital stay did not differ between the two
roups.
iscussion
espite continuous development in minimizing surgical,
ABLE 2. Perioperative data
GA GATEA P value
perative time (min) 121 45 108  54 NS
o. of distal anastomoses 2.3 1.1 2.0  1.0 NS
lood loss (mL) 420 232 380  208 NS
entilation time (h) 7.0 4.2 6.0  2.3 NS
F 18 2 .01
entricular extrasystoles (counts) 18 2 .01
inus tachycardia 32 6 .01
inus bradycardia 4 60 .01
entricular fibrillation 1 1 NS
ime of onset of AF (d) 2.0 1.4 1.9  1.3 NS
A, General anesthesia; TEA, high thoracic epidural anesthesia; NS, not
ignificant; AF, atrial fibrillation.nesthesiologic, or cardiopulmonary bypass trauma in CABG
st 2007
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A
CDrocedures, perioperative morbidity and clinical complica-
ions are still significant.14 AF remains one of the m
requent complications in patients undergoing CABG, and it
ay lead to increased morbidity and length of hospital stay.
mbalance in the autonomic nervous system may cause
hanges in sinus node function and electrical atrial conduc-
ion as well as refractoriness previously shown to be related
o the propensity for AF. Surgical trauma associated with
ncreased sympathetic stimulation may also be a trigger for
he onset of AF.7,8
The current prospective randomized study was designed
o investigate the impact of the TEA on the incidence of
erioperative arrhythmias with major attention to AF. The
erioperative use of GA in combination with TEA in our
tudy cohort led to stress-response attenuation and intense
erioperative analgesia. We demonstrated that patients in
he GATEA group had a significantly lower incidence of
F and ventricular extrasystoles. In the GATEA group,
erum levels of epinephrine were significantly lower, which
ay support the hypothesis in regard to preventing the
mbalance of sympathetic activity.
TEA seems to attenuate the secretion of epinephrine
rom the adrenal gland, which may have a positive effect on
he balance within the autonomous nervous system. The
ffect of TEA on heart rate and blood pressure is also in
ccordance with this observation. Inhibition of sympathetic
ctivity during the perioperative period may reduce postop-
rative myocardial ischemia.15 This effect is most related 
he balance of myocardial oxygen demand and supply. Most
pisodes of myocardial ischemia occur in the absence of
ajor hemodynamic changes.16,17 Thus, the use of TEA 
atients with significant coronary artery disease may im-
rove oxygen supply, so long as blood pressure is main-
ained in a relatively normal range. These effects also fa-
ilitate beating heart surgery in regard to suturing conditions
ith a lower heart rate and blood pressure.
Our data support the hypothesis that perioperative im-
igure 1. Intraoperative heart rate monitoring. A, Before induc-
ion of anesthesia; B, sternotomy; C, before anastomosis; D, after
nastomosis; E, sternal closure. GA, General anesthesia; TEA,
igh thoracic epidural anesthesia.alance of the autonomic nervous system may lead to a
The Journal of Thoracicigher incidence of AF. We believe the reduced incidence
f AF in our study cohort was related to sympathicolytic
roperties of TEA.
Furthermore, perioperative myocardial ischemia may be
ggravated by sympathetic nerve activation, which disturbs
he balance between coronary blood flow and myocardial
xygen demand.16,17
Recent studies have also shown that ropivacaine has a
ubstantial anti-inflammatory effect. Blumenthal and asso-
iates18 could demonstrate that ropivacaine has strong a
nflammatory effects on neutrophils and endothelial cells
oth in vitro and in vivo.
In our study we could not measure any inflammatory
arameters between the groups. However, we speculate that
EA may also decrease the systemic inflammatory response
nd consequently the development of AF.
tudy Limitations
he study investigates a small number of patients. All patients
ere preselected by an anesthesiologist for eligibility to re-
eive an epidural catheter before randomization. Patients with
ontraindications for TEA were excluded from the study. We
id not measure any inflammatory parameters. Overall, longer
ollow-up periods and also a larger number of patients are
ecessary to corroborate our findings.
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